Topical antifungals

Definition and Clinical Significance

Topical antifungals are pharmacologic agents applied directly to the skin, nails, scalp, or mucous membranes for the treatment of superficial fungal infections. They act locally at the site of infection, minimizing systemic absorption and associated side effects. These agents are widely used in the management of dermatophytoses (tinea infections), cutaneous candidiasis, seborrheic dermatitis, pityriasis versicolor, and fungal nail infections (onychomycosis).

Fungal skin infections are common worldwide and often caused by dermatophytes (Trichophyton, Microsporum, Epidermophyton species), yeasts (Candida, Malassezia), and occasionally molds. Topical antifungals are the first-line therapy for mild to moderate localized infections and serve as adjuncts in systemic therapy for more extensive or resistant cases.

---

Mechanisms of Action

Topical antifungal agents function through various mechanisms to inhibit or destroy fungal cells:

1. Inhibition of ergosterol synthesis – disrupts fungal cell membrane integrity
   (e.g., azoles, allylamines, benzylamines)

2. Binding to fungal cell membrane sterols – increases permeability and causes leakage of intracellular contents
   (e.g., polyenes like nystatin)

3. Inhibition of fungal mitosis or DNA synthesis – less common
   (e.g., ciclopirox, amorolfine)

4. Disruption of fungal cell wall synthesis – rarely used topically (mainly echinocandins systemically)

---

Major Pharmacological Classes of Topical Antifungals

1. Azoles

   • Mechanism: Inhibit 14-α-demethylase, an enzyme in the ergosterol biosynthesis pathway.

   • Drugs:

     • Clotrimazole

     • Miconazole

     • Ketoconazole

     • Econazole

     • Oxiconazole

     • Sertaconazole

     • Bifonazole

     • Tioconazole (used especially for onychomycosis)

   • Indications: Tinea corporis, cruris, pedis, versicolor; cutaneous candidiasis; seborrheic dermatitis.

   • Advantages: Broad-spectrum antifungal and antibacterial activity; favorable safety profile.

2. Allylamines

   • Mechanism: Inhibit squalene epoxidase, leading to ergosterol depletion and fungal cell death.

   • Drugs:

     • Terbinafine

     • Naftifine

     • Butenafine (classified as benzylamine but with similar action)

   • Indications: Dermatophyte infections, especially tinea pedis, cruris, and corporis.

   • Advantages: Fungicidal; shorter duration of treatment; high efficacy.

3. Polyenes

   • Mechanism: Bind to ergosterol in fungal membranes, forming pores that disrupt membrane integrity.

   • Drugs:

     • Nystatin (topical and oral)

     • Amphotericin B (limited topical use)

   • Indications: Cutaneous and mucocutaneous candidiasis, especially oral and vaginal infections.

   • Limitation: No activity against dermatophytes.

4. Hydroxypyridones

   • Mechanism: Inhibit metal-dependent fungal enzymes (DNA/RNA synthesis, mitochondrial function).

   • Drugs:

     • Ciclopirox olamine

   • Indications: Tinea infections, seborrheic dermatitis, onychomycosis.

   • Advantages: Broad-spectrum activity; anti-inflammatory effects.

5. Morpholines

   • Mechanism: Inhibit Δ14-reductase and Δ7–Δ8 isomerase, enzymes involved in ergosterol synthesis.

   • Drugs:

     • Amorolfine (used topically in nail lacquers)

   • Indications: Onychomycosis (superficial).

   • Limitation: Slower onset, long treatment duration.

6. Miscellaneous Agents

   • Tolnaftate: Distorts fungal hyphae; used for tinea pedis and corporis.

   • Undecylenic acid: Fungistatic; available in creams or powders.

   • Benzoic acid + Salicylic acid (Whitfield’s ointment): Keratolytic and antifungal combination.

   • Selenium sulfide (used for pityriasis versicolor): Reduces fungal load and sebum.

---

Indications for Topical Antifungals

1. Dermatophytoses (Tinea infections)

   • Tinea corporis (body)

   • Tinea cruris (groin)

   • Tinea pedis (athlete’s foot)

   • Tinea manuum (hands)

   • Tinea faciei (face)

   • Tinea capitis (adjunct only)

   • Tinea unguium (limited efficacy; best for mild superficial onychomycosis)

2. Cutaneous Candidiasis

   • Intertrigo (skin folds)

   • Diaper rash

   • Angular cheilitis

   • Candidal balanitis

3. Pityriasis Versicolor

   • Caused by Malassezia species

   • Treated with azoles or selenium sulfide

4. Seborrheic Dermatitis

   • Ketoconazole creams and shampoos are preferred

5. Oral and Vaginal Candidiasis

   • Nystatin (oral suspension)

   • Miconazole buccal tablets or vaginal suppositories

6. Onychomycosis

   • Amorolfine and ciclopirox lacquers for superficial infections

---

Commonly Prescribed or OTC Topical Antifungals and Their Brands

Generic Name	Brand Names	Formulations	Indications
Clotrimazole	Canesten, Lotrimin	Cream, solution, vaginal tablet	Candidiasis, tinea, diaper rash
Miconazole	Daktarin, Micatin	Cream, powder, oral gel	Tinea, oral/vaginal candidiasis
Ketoconazole	Nizoral	Cream, shampoo	Seborrheic dermatitis, tinea
Terbinafine	Lamisil	Cream, gel, spray	Tinea, onychomycosis
Naftifine	Naftin	Cream, gel	Tinea
Butenafine	Lotrimin Ultra	Cream	Tinea pedis
Nystatin	Mycostatin, Nystan	Cream, ointment, oral suspension	Candidiasis (skin/oral/vaginal)
Ciclopirox	Loprox, Penlac	Cream, lacquer, shampoo	Seborrheic dermatitis, nails
Amorolfine	Loceryl	Nail lacquer	Onychomycosis
Tolnaftate	Tinactin	Cream, powder, spray	Dermatophyte infections

Dosing and Duration

• Most topical antifungals are applied once or twice daily.

• Duration depends on infection type and drug class:

  • Tinea corporis/cruris: 2–4 weeks

  • Tinea pedis: 4–6 weeks

  • Cutaneous candidiasis: 1–2 weeks

  • Onychomycosis (lacquers): 6–12 months

---

Adverse Effects

Generally well tolerated, but localized reactions may occur:

1. Common Local Reactions:

   • Burning

   • Stinging

   • Erythema

   • Itching

   • Skin peeling

2. Allergic Contact Dermatitis:

   • May occur with azoles or polyenes.

3. Photosensitivity:

   • Rare; reported with some allylamines.

4. Systemic Effects:

   • Minimal due to poor dermal absorption.

   • Exception: extensive application on broken skin or in infants.

---

Contraindications and Precautions

• Hypersensitivity to drug components.

• Avoid occlusive dressings unless instructed.

• Do not apply on open wounds or mucosal tissues unless labeled for such use.

• Use cautiously in infants and elderly due to thinner skin and increased absorption risk.

---

Drug Interactions

• Minimal systemic interaction due to poor absorption.

• Polyene-antibacterial combinations (e.g., nystatin with neomycin) may interact or cause skin sensitization.

• Azoles may interact locally with barrier creams or other topical products affecting skin pH.

---

Clinical Tips for Effective Use

• Wash and dry the affected area before application.

• Continue treatment for a few days after symptoms resolve to prevent recurrence.

• Avoid sharing topical medications.

• Apply thin layers and avoid overuse.

• For tinea pedis, consider using powders to keep feet dry.

---

Professional Guidelines and Recommendations

• First-line for superficial infections: topical azoles or allylamines

• Combination therapy: not generally necessary unless co-infection (e.g., fungal + bacterial)

• Recurrence management: Emphasize hygiene, drying, and environmental control (shoes, socks, etc.)

• Special populations:

• Pregnant women: Nystatin and clotrimazole are generally considered safe.

• Children: Clotrimazole, miconazole, and nystatin are preferred